You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Safety of dual biological therapy in Crohn’s disease: a case series of vedolizumab in combination with other biologics

Article metrics

Article menu

Download PDFPDF

XML
Case report
Safety of dual biological therapy in Crohn’s disease: a case series of vedolizumab in combination with other biologics

 

Online download statistics by month:

Online download statistics by month: November 2018 to August 2024

AbstractFullPdf
Nov 2018959537
Dec 2018289289107
Jan 2019246238102
Feb 201912612358
Mar 201918818556
Apr 201918518249
May 201920019646
Jun 201919319348
Jul 201921321353
Aug 201921721159
Sep 201916416342
Oct 201919619446
Nov 201916015657
Dec 201915414848
Jan 202018718560
Feb 202018517573
Mar 202017717161
Apr 202012712643
May 202013512759
Jun 202016315758
Jul 202014213152
Aug 202011410337
Sep 2020927462
Oct 2020998462
Nov 2020837347
Dec 2020605754
Jan 2021716250
Feb 2021635749
Mar 2021595151
Apr 2021605546
May 2021554939
Jun 2021736733
Jul 2021474225
Aug 2021544939
Sep 2021534939
Oct 2021474359
Nov 2021494843
Dec 2021504621
Jan 2022686026
Feb 2022625456
Mar 2022675638
Apr 2022403923
May 2022726443
Jun 2022585044
Jul 2022494719
Aug 2022584728
Sep 2022515040
Oct 2022332825
Nov 2022595330
Dec 2022303120
Jan 202313312523
Feb 202355539
Mar 20231099945
Apr 2023505415
May 2023909017
Jun 202332355
Jul 2023434314
Aug 2023513021
Sep 202344417
Oct 2023403116
Nov 202351517
Dec 2023717010
Jan 2024252416
Feb 202440397
Mar 2024534616
Apr 2024565511
May 202426278
Jun 2024352913
Jul 2024362811
Aug 2024353010
Total659362462643